IL146745A0 - Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor - Google Patents

Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor

Info

Publication number
IL146745A0
IL146745A0 IL14674500A IL14674500A IL146745A0 IL 146745 A0 IL146745 A0 IL 146745A0 IL 14674500 A IL14674500 A IL 14674500A IL 14674500 A IL14674500 A IL 14674500A IL 146745 A0 IL146745 A0 IL 146745A0
Authority
IL
Israel
Prior art keywords
activation
protection
reactive oxygen
cytotoxic lymphocytes
oxygen metabolite
Prior art date
Application number
IL14674500A
Other languages
English (en)
Original Assignee
Maxim Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharm Inc filed Critical Maxim Pharm Inc
Publication of IL146745A0 publication Critical patent/IL146745A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01011—L-ascorbate peroxidase (1.11.1.11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14674500A 1999-07-16 2000-07-14 Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor IL146745A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14439499P 1999-07-16 1999-07-16
PCT/US2000/019407 WO2001006756A2 (en) 1999-07-16 2000-07-14 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes

Publications (1)

Publication Number Publication Date
IL146745A0 true IL146745A0 (en) 2002-07-25

Family

ID=22508390

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14674500A IL146745A0 (en) 1999-07-16 2000-07-14 Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor

Country Status (12)

Country Link
US (1) US20040120926A1 (ja)
EP (1) EP1200074A2 (ja)
JP (1) JP2003505348A (ja)
KR (1) KR20020016844A (ja)
CN (1) CN1379664A (ja)
AU (1) AU779215B2 (ja)
CA (1) CA2377247A1 (ja)
HK (1) HK1046368A1 (ja)
IL (1) IL146745A0 (ja)
NZ (1) NZ515859A (ja)
WO (1) WO2001006756A2 (ja)
ZA (1) ZA200109655B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004258801A1 (en) * 2003-02-28 2005-02-03 Inotek Pharmaceuticals Corporation Tetracyclic Benzamide Derivatives and methods of use thereof
EP1722797A4 (en) * 2004-02-26 2008-03-19 Inotek Pharmaceuticals Corp ISOCHINOLINE DERIVATIVES AND METHOD FOR THE APPLICATION THEREOF
WO2005082079A2 (en) * 2004-02-26 2005-09-09 Inotek Pharmaceuticals Corporation Tetracyclic lactam derivatives and uses thereof
JP2008503466A (ja) * 2004-06-16 2008-02-07 イノテック ファーマシューティカルズ コーポレイション 勃起不全または尿失禁を治療または予防する方法
WO2006039545A2 (en) * 2004-09-30 2006-04-13 Maxim Pharmaceuticals, Inc. Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis
KR20070116016A (ko) * 2005-02-25 2007-12-06 이노텍 파마슈티컬스 코포레이션 이소퀴놀린 화합물 및 그의 이용 방법
KR20070116011A (ko) * 2005-02-25 2007-12-06 이노텍 파마슈티컬스 코포레이션 테트라사이클릭 아미노 및 카복사미도 화합물 및 이의 이용방법
US20060287311A1 (en) * 2005-02-25 2006-12-21 Inotek Pharmaceuticals Corporation Tetracyclic Sulfonamide Compounds and methods of use thereof
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
JP2009506060A (ja) * 2005-08-24 2009-02-12 イノテック ファーマシューティカルズ コーポレイション インデノイソキノリノン類縁体及びそれらの使用方法
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
CA2673511A1 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
CA2677046A1 (en) * 2007-02-28 2008-09-04 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
JP6556121B2 (ja) * 2013-04-29 2019-08-07 アポジェニックス アーゲー 癌を診断する方法
WO2019023263A1 (en) * 2017-07-25 2019-01-31 Immune Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR TREATING TUMORS COMPRISING A BCR-ABL1 FUSION GENE
EP3700512A4 (en) * 2017-10-24 2021-08-11 Lunella Biotech, Inc. MITOFLAVOSCINE: TARGETING FLAVINAL ENZYMES ELIMINATES CANCER STEM CELLS (CSCS) BY INHIBITING MITOCHONDRIAL BREATHING
KR102053545B1 (ko) 2018-08-30 2019-12-06 동아대학교 산학협력단 디페닐리오도니움을 포함하는 항진균 및 항균용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA741203B (en) * 1973-03-23 1975-01-29 Smithkline Corp Veterinary feed compositions for inhibiting rumen microbial deamination
ES2087163T3 (es) * 1989-09-19 1996-07-16 Syntello Inc Preparacion antitumoral que comprende intreleucina-2 e histamina, analogo al de las mismas o agonistas de receptor h2.
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
US5780513A (en) * 1996-08-22 1998-07-14 Washington University Method of inhibiting the release of bioactive IL-1
US6498181B1 (en) * 1999-01-06 2002-12-24 Maxim Pharmaceuticals Synergistic tumorcidal response induced by histamine

Also Published As

Publication number Publication date
US20040120926A1 (en) 2004-06-24
WO2001006756A2 (en) 2001-01-25
KR20020016844A (ko) 2002-03-06
JP2003505348A (ja) 2003-02-12
CA2377247A1 (en) 2001-01-25
AU6104400A (en) 2001-02-05
CN1379664A (zh) 2002-11-13
ZA200109655B (en) 2002-10-30
NZ515859A (en) 2004-02-27
HK1046368A1 (zh) 2003-01-10
EP1200074A2 (en) 2002-05-02
WO2001006756A3 (en) 2001-11-15
AU779215B2 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
IL146745A0 (en) Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor
AU2054001A (en) Electroactive materials and beneficial agents having a solublizing moiety
ZA989937B (en) Creped nonwoven materials and liner
AU2797699A (en) Passivating a gas vessel and article produced
IL126267A0 (en) A novel composition for controlled and sustained transdermal administration
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
EP1071403A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING STATIN AND ASPIRIN
PL337348A1 (en) Pharmaceutic composition comprising a combination of piperidinylalkanol and a decongestant
SI0979269T1 (en) Use of a fermenter
AU9203898A (en) Cyclosporin a conjugates and uses therefor
HK1029530A1 (en) Combination pharmaceutical form comprising amlodipine and a statin compound
FR2792492B1 (fr) Cartouche pour torche a plasma et torche a plasma equipee
GB9900227D0 (en) Use of a composition
IL125732A0 (en) Crystal modification of a pharmaceutical agent
FR2792493B1 (fr) Cartouche pour torche a plasma et torche a plasma equipee
AU2001270193A1 (en) Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
AU781786C (en) Radioprotective materials and utilization thereof
IL144339A0 (en) A cell line containing gamma delta lymphocytes and pharmaceutical compositions containing the same
IL147507A0 (en) T-cell receptor y and uses thereof
IL149310A0 (en) Oral solution containing galanthamine and a sweetening agent
HUP0201880A3 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
HUP0105097A2 (en) Pharmaceutical mixtures comprising a combination of a profen and other active compounds
AU3852800A (en) A construction and use thereof
GB2341536B (en) A rack and use thereof
AU3435701A (en) Protective pocket and method of making a protective pocket